China SXT Pharmaceuticals Inc (SXTC)
1.03
-0.03
(-2.83%)
USD |
NASDAQ |
May 01, 16:00
1.01
-0.02
(-1.94%)
After-Hours: 20:00
China SXT Pharmaceuticals Net Income (TTM): -14.14M for Sept. 30, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| September 30, 2023 | -14.14M |
| March 31, 2023 | -5.935M |
| September 30, 2022 | -4.139M |
| March 31, 2022 | -5.736M |
| September 30, 2021 | -7.221M |
| March 31, 2021 | -2.748M |
| Date | Value |
|---|---|
| September 30, 2020 | -6.558M |
| March 31, 2020 | -10.29M |
| September 30, 2019 | -1.804M |
| March 31, 2019 | 1.539M |
| September 30, 2018 | 1.395M |
| March 31, 2018 | 1.188M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-14.14M
Minimum
Sep 2023
-1.804M
Maximum
Sep 2019
-6.507M
Average
-5.935M
Median
Mar 2023
Net Income (TTM) Benchmarks
| Jin Medical International Ltd | 2.878M |
| Sinovac Biotech Ltd | -353.73M |
| CASI Pharmaceuticals Inc | -26.94M |
| Zai Lab Ltd | -334.62M |
| I-MAB | -315.57M |